Form Health

Form Health

Hospitals and Health Care

Boston, Massachusetts 3,609 followers

Form Health is the national leader in science-based obesity care.

About us

Form Health is the national leader in science-based obesity care. Our clinical care model consists of one-on-one, personalized care from a dedicated ABOM-certified physician and a CSOWM-certified Registered Dietitian, who develop individualized treatment plans that address nutrition, physical activity, mindset shifts, and include a prescription for FDA-approved medication, if appropriate. Form Health keeps safety, efficacy, and outcomes at the forefront as we incorporate the latest research and science into our approach. This means we’re always innovating, constantly getting smarter about the science of obesity care, relentlessly focusing on exceptional results, and calling out harmful practices that hold back progress. The result is life-changing outcomes for our patients and meaningful ROI for our enterprise partners. Form Health is in-network with national health plans. Learn more at formhealth.co.

Website
http://formhealth.co
Industry
Hospitals and Health Care
Company size
51-200 employees
Headquarters
Boston, Massachusetts
Type
Privately Held
Founded
2019

Locations

  • Primary

    109 State St

    5th Floore

    Boston, Massachusetts 02109, US

    Get directions

Employees at Form Health

Updates

  • View organization page for Form Health, graphic

    3,609 followers

    The European Association for the Study of Obesity recently released a new framework for the diagnosis and management of obesity. Form Health Chief Medical Officer, Florencia Halperin, explains how this framework aligns with Form's comprehensive approach to obesity treatment. This new framework underscores the importance of a thorough medical evaluation and individualized treatment plans, which is at exactly how we provide care at Form Health. Want to learn more about our science-based, individualized approach? Reach out to [email protected].

    View profile for Florencia Halperin, graphic

    Chief Medical Officer, Form Health

    A really important framework for the diagnosis, staging and management of obesity was published this month by the European Association for the Study of Obesity (https:/https://lnkd.in/euxKbHaG). I could not agree more with this figure and this is so aligned with the work that we do with patients at Form Health every day. Treatment decisions are not just about weight. They are about considering all of the physical and emotional health impacts on the individual, and their unique goals of treatment. This is not a cookie-cutter process of prescribing one class of medications, but one that requires an in-depth medical evaluation and shared decision making. And treatment plans are not one and done, they require careful consideration to start and then ongoing monitoring and evolution over time, depending on the results. So great to see more and more thought leadership emerging on this, and at the international level. Science, evidence, guidelines, and expert consensus are a counter-weight to hype, misconception and misinformation about what it means to have obesity and its medical treatment options.

    A new framework for the diagnosis, staging and management of obesity in adults - Nature Medicine

    A new framework for the diagnosis, staging and management of obesity in adults - Nature Medicine

    nature.com

  • View organization page for Form Health, graphic

    3,609 followers

    Form Health Chief Medical Officer Florencia Halperin supports the Patient-Centered Outcome Measures for adults with obesity released by the International Consortium for Health Outcomes Measurement (ICHOM) . These measures emphasize the importance of evaluating health impacts beyond weight, including mental health, energy, daily physical functioning, sleep, and metabolic parameters. Check out her full thoughts below. At Form Health, each patient works with a dedicated obesity medicine physician and Registered Dietitian to achieve their goals including weight loss, health improvements, and meaningful non-scale victories. Want to learn more about our science-based, individualized approach? Reach out to [email protected].

    View profile for Florencia Halperin, graphic

    Chief Medical Officer, Form Health

    A set of Patient-Centered Outcome Measures for Adults living with Obesity was released by the experts convened by the International Consortium for Health Outcomes Measurement. This important work emphasizes that treatment of obesity is not about the number on the scale! We need to (re)focus on the many ways treating obesity affects people's health and wellbeing (especially in this crazy time of people getting unregulated and knock-off products with minimal medical supervision!). This group proposes specific measures to track for critical aspects like mental health, energy, physical functioning for daily activities, sleep, as well as the metabolic parameters like blood sugars, blood pressure and cholesterol. I think following how different treatments affect health metrics beyond the scale will also be critical over time to understand which treatments are best for which individuals, as we have more and more therapy options becoming available. The proposed measures are an incredible list of those "non-scale victories" we need to be focusing on for the treatment of obesity!

    Adult Obesity

    https://www.ichom.org

  • View organization page for Form Health, graphic

    3,609 followers

    Form Health Physician Lauren Lemieux, MD, FACP, DABOM shares new research that may lead to the reduction of nausea as a side effect of GLP-1 medications. Check it out!

    View profile for Lauren Lemieux, MD, FACP, DABOM, graphic

    Lead Obesity Medicine Physician at Form Health

    Nausea is an extremely common side effect of GLP-1 medications like Wegovy and Ozempic, and in some cases I’ve had patients discontinue their medication as a result. This study highlights how targeting certain GLP-1 receptors in a specific area of the brain (nucleus tractus solitarius) can lead to a reduction in appetite without nausea and may one day be a target for drug therapy. https://lnkd.in/g8QrBBMW

    Discovery could help reduce adverse side effects of popular next-generation obesity medications

    Discovery could help reduce adverse side effects of popular next-generation obesity medications

    sciencedaily.com

  • View organization page for Form Health, graphic

    3,609 followers

    Did you know that obesity is a significant risk factor for many cancers? GLP-1s may be able to help. Recent research suggests that GLP-1 treatments for obesity may reduce the risk of developing 10 different types of obesity-related cancers. Dr. Florencia Halperin, Chief Medical Officer comments, "These are very exciting findings as we work to mitigate the health risks associated with obesity and diabetes and improve the overall health of our population." At Form Health, we treat obesity as a chronic disease with a science-based, comprehensive approach. Patients experience weight loss and improved health. Is your organization seeking an impactful and cost-effective solution to address the high cost of weight-related health conditions? Contact us at [email protected] to learn how we can help.

    View profile for Florencia Halperin, graphic

    Chief Medical Officer, Form Health

    While many people know that obesity is a risk factor for metabolic diseases like diabetes, a less-known fact about the disease of obesity is that it is a very significant risk factor for many cancers. For some types of cancer, obesity rivals or has even surpassed smoking as the leading modifiable risk factor. Obesity may also increase the risk of cancer recurrence and mortality in cancer survivors. This all puts into perspective some very exciting data published last week which suggests GLP-1 receptor agonist treatment may decrease the risk of developing 10 different types of obesity-associated cancers. This was in a large population of people with diabetes, and more research is needed to corroborate this and understand impact in different populations, but these are very exciting findings as we work to improve the health risks associated with obesity and diabetes and improve the health of our population!

    GLP-1RAs and Obesity-Associated Cancers in Patients With Type 2 Diabetes

    GLP-1RAs and Obesity-Associated Cancers in Patients With Type 2 Diabetes

    jamanetwork.com

  • View organization page for Form Health, graphic

    3,609 followers

    Curious about what it's like to work at Form Health? Visit our LinkedIn Life page to get a glimpse of what it's like to be part of our dynamic, hardworking team. We are working together to change lives through science-based obesity care. Are you passionate about helping patients achieve their weight loss and health goals through an evidence-based clinical approach? Join our talented team! Explore our career opportunities: https://lnkd.in/dZUp2V6p.

    Form Health: Culture | LinkedIn

    Form Health: Culture | LinkedIn

    linkedin.com

  • View organization page for Form Health, graphic

    3,609 followers

    Weight loss has long been a challenging topic for both patients and physicians, often preventing those living with obesity and overweight from seeking medical treatment altogether. Weight stigma and bias have no place in healthcare. At Form Health, we recognize obesity as a complex, chronic medical condition. Our team of expert doctors, Advanced Practice Providers (APPs), and Registered Dietitians work together to provide nonjudgmental, empathetic, and evidence-based obesity care for all. Want to learn more? Email us at [email protected].

    Opinion | Weight Stigma Is Bad Medicine

    Opinion | Weight Stigma Is Bad Medicine

    medpagetoday.com

  • View organization page for Form Health, graphic

    3,609 followers

    Form Health physician Nat Pedley shares what it's like to be part of the Form team and how practicing telemedicine provides an opportunity to build meaningful relationships with his patients. Excited about making a difference in healthcare and helping patients reach their weight loss and health goals? Join our team of obesity medicine specialists! Explore our job opportunities: https://lnkd.in/dZUp2V6p

  • View organization page for Form Health, graphic

    3,609 followers

    Form Health is thrilled to announce our Series B funding. Form was founded to fundamentally change the way obesity care is delivered to Americans. We keep safety, efficacy, and outcomes at the forefront as we incorporate the latest research and science into our approach. This means we’re always innovating, constantly getting smarter about the science of obesity care, relentlessly focusing on exceptional results, and calling out harmful practices that hold back progress. The result is life-changing outcomes for our patients and meaningful ROI for our partners. With the new funding, we’ll be expanding our work with our enterprise partners, including employers, consultants and health plans, deeply investing in product and accelerating the hiring of ABOM-certified physicians to keep up with extraordinary patient demand. Thank you to the team at Sound Ventures for partnering with us during this exciting period of our growth, and the folks at M13, SignalFire, and NextView Ventures for continuing to believe in our mission to greatly expand access to science-based obesity care.

  • View organization page for Form Health, graphic

    3,609 followers

    FORM CMO Florencia Halperin reinforces the importance of nutritional support for patients taking GLP-1 and GIP receptor agonists. Registered Dietitians can play a critical role in helping patients manage any risk of malnutrition and set sustainable dietary goals during AOM therapy. At FORM patients receive comprehensive obesity care by working 1:1 with both an ABOM doctor and a CSOWM Registered Dietitian. Want to learn more about our science-based approach? Reach out to [email protected].

    View profile for Florencia Halperin, graphic

    Chief Medical Officer, Form Health

    All of us who are actively treating patients with obesity using the newest, highly effective medications (GLP-1 +/- GIP receptor agonists) are seeing how important it is to give our patients nutrition support and education as their appetites become suppressed and their cravings subside. But we don't have a ton of current data to guide nutritional recommendations during AOM therapy specifically. This recent review highlights that nutritional assessment and counseling of patients on AOMs can help us identify and manage risk factors for malnutrition, develop goals for intake of key nutrients like protein, fiber, vitamins, and fluids. Not that we were looking for any additional reason to love working with our registered dietitian colleagues, but it is great to read an evidence-based review that highlights their crucial role in obesity care even when people use highly effective AOMs. My patients and I are so lucky to have the incredible RDs on our team at FORM │ Virtual obesity medicine clinic.

    onlinelibrary.wiley.com

Similar pages

Browse jobs

Funding

Form Health 3 total rounds

Last Round

Series B

US$ 38.0M

See more info on crunchbase